UNITED STATES SECURITIES AND EXCHANGE
COMMISSION Washington, D.C. 20549  FORM
10-Q (Mark One)  x**QUARTERLY REPORT PURSUANT TO SECTION 13 OR
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**  For the quarterly period ended June
30, 2009  or   o**TRANSITION REPORT PURSUANT TO SECTION 13 OR
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**  For the transition period from
____________ to ________________  Commission file number:
333-139699  CYTTA CORP.(Exact name of Registrant as specified
in its charter)Nevada

98-0505761(State or other jurisdiction of
incorporation or organization)

(IRS Employer Identification
No.)905 Ventura Way, Mill Valley, CA
 94941(Address of principal executive
offices)(415) 860-5192(Registrants telephone number,
including area code)Suite 640, 602  12th
Avenue S.W.,
Calgary, AB  Canada  T2R
1J3(Former name, former address and
former fiscal year, if changed since last report)  Indicate by check mark
whether the Registrant (1) has filed all reports required to be filed by Section
13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12
months (or for such shorter period that the Registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90
days.  Yes x  No o  Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation
S-T (§232.405 of this chapter) during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such files).
 Yes o  No x Indicate by check mark whether the Registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of large accelerated filer,
accelerated filer, and smaller reporting company in Rule 12b-2 of the
Exchange Act (Check one).  Large accelerated filer o

Accelerated filer oNon-accelerated filer o

Smaller reporting company x(Do not check if a smaller reporting
company)  Indicate by check mark
whether the Registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act). Yes o No x  As of August 13, 2009,
there were 661,400,000 shares of the issuers common stock, par value $0.00001,
outstanding.


PART I  FINANCIAL INFORMATION ITEM
1. FINANCIAL
STATEMENTS The
accompanying unaudited financial statements have been prepared in accordance
with accounting principles generally accepted in the United States of America
and the rules of the Securities and Exchange Commission ("SEC"), and should be
read in conjunction with the audited financial statements and notes thereto
contained in the Company's Form 10-K filed with the SEC on December 2, 2008. In
the opinion of management, all adjustments, consisting of normal recurring
adjustments, necessary for a fair presentation of financial position and the
results of operations for the periods presented have been reflected herein. The
results of operations for the periods presented are not necessarily indicative
of the results to be expected for the full year ended September 30, 2009.





CYTTA CORP. (A Development Stage Company)  INTERIM FINANCIAL STATEMENTS  JUNE 30, 2009  (Unaudited)





Cytta Corp. (A Development Stage Company) Balance Sheets     ASSETSAs
of


As ofJune
30,


September
30,2009


2008(Unaudited)CURRENT ASSETSCash and cash
equivalents
$
136

$
34,536NON-CURRENT
ASSETSIntangible assets, net

119,605


-TOTAL ASSETS
$
119,741

$
34,536LIABILITIES
AND STOCKHOLDERS EQUITYCURRENT
LIABILITIESAccounts payable and accrued
liabilities
$
9,140

$
9,165Due to
related party (Note 5)

6,770


-TOTAL LIABILITIES

15,910


9,165STOCKHOLDERS'
EQUITYCapital
Stock (Note 3)Authorized:100,000,000
preferred shares, $0.001 par value1,900,000,000
common shares, $0.00001 par valueIssued and outstanding
shares:605,400,000
(484,000,000 - Sept. 30) common shares

6,054


4,840Additional paid-in capital

409,386


81,16056,000,000 common shares
pending cancellation

560


-Deficit accumulated during the
development stage

(312,169)


(60,629)Total Stockholders'
Equity

103,831


25,371TOTAL LIABILITIES AND
STOCKHOLDERS' EQUITY
$
119,741

$
34,536    -The accompanying notes
are an integral part of these financial statements


4


Cytta Corp. (A Development Stage Company) Interim Statements of Operations (Unaudited)   Cumulative
fromInception(May 30, 2006)
toThree Months Ended
June 30,


Nine Months Ended
June 30,


June 30,2009


2008


2009


2008


2009REVENUES

$
-

$
-

$
-

$
-

$
-OPERATING EXPENSES
(RECOVERY)Professional fees


9,836


3,040


29,058


8,295


69,777General and administrative
(recovery)


(164,056)


5,567


222,482


19,327


242,392Total Operating Expenses
(Recovery)


(154,220)


8,607


251,540


27,622


312,169Other Income
(Expense)


-


-


-


-


-Provision
for Income Taxes(Note
4)


-


-


-


-


-Net Income (Loss)

$
154,220

$
(8,607)

$
(251,540)

$
(27,622)

$
(312,169)PER SHARE DATA:Basic and diluted loss percommon share

$
0.00

$
(0.00)

$
(0.00)

$
(0.00)Weighted average number
ofcommon shares
outstanding


962,342,333


484,000,000


1,108,037,463


484,000,000    -The accompanying notes
are an integral part of these financial statements -


5


Cytta Corp. (A Development Stage Company) Interim Statements of Cash Flows (Unaudited)   Cumulative fromInception(May 30, 2006) toNine Months Ended June 30,

June 30,2009


2008

2009OPERATING
ACTIVITIESNet
loss
$
(251,540)

$
(27,622)

$
(312,169)Adjustments to reconcile net loss to net cash used
in operating activities:Amortization and depreciation

395





395Changes
in Operating Assets and Liabilities:Decrease
in prepaid expenses

-


818


-Increase
(decrease) in accounts payable and accrued liabilities

(25)


(1,499)


9,140Net
Cash Used in Operating Activities

(251,170)


(28,303)


(302,634)INVESTING
ACTIVITIESNet
Cash Provided by (Used in) Investing Activities

-


-


-FINANCING
ACTIVITIESIssuance
of capital stock

209,440


-


295,440Capital
stock pending cancellation

560


-


560Advances
from a related party

6,770


-


6,770Net
Cash Provided by Financing Activities

216,770


-


302,770NET
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

(34,400)


(28,303)


136CASH
AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

34,536


63,009


-CASH
AND CASH EQUIVALENTS AT END OF PERIOD
$
136

$
34,706

$
136Supplemental
Cash Flow Disclosures:Cash
paid for Interest
$
-

$
-

$
-Cash
paid for Income Taxes
$
-

$
-

$
-Non-Cash
Financing and Investing Activities:Common
stock issued for licensing agreement
$
120,000

$
-

$
120,000   -The accompanying notes
are an integral part of these financial statements -


6


Cytta Corp. (A Development Stage Company) Notes to Interim Financial Statements June 30, 2009 (Unaudited)    NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS  Cytta Corp., (the Company) was incorporated on May 30, 2006
under the laws of the State of Nevada.  It is located in Vancouver, British
Columbia, Canada.  The accounting and reporting policies of the Company
conform to accounting principles generally accepted in the United States of
America, and the Companys fiscal year end is September 30. The Company is a development stage company that intends to
manufacture, distribute and market various telephony based internet access and
computing products and services. To date, the Companys activities have been
limited to its formation and the raising of equity capital.  NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  Use of Estimates  The preparation of financial statements in conformity with
accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and the reported amount of
revenues and expenses during the reporting period.  Actual results could
differ from those estimates. The Companys periodic filings with the Securities
and Exchange Commission include, where applicable, disclosures of estimates,
assumptions, uncertainties and markets that could affect the financial
statements and future operations of the Company. Cash and Cash Equivalents  Cash and cash equivalents include cash in banks, money market
funds, and certificates of term deposits with maturities of less than three
months from inception, which are readily convertible to known amounts of cash
and which, in the opinion of management, are subject to an insignificant risk of
loss in value.  The Company had $136 and $34,536 in cash and cash
equivalents at June 30, 2009 and September 30, 2008, respectively.


7


Cytta Corp. (A Development Stage Company) Notes to Interim Financial Statements June 30, 2009 (Unaudited)   Start-Up Costs  In accordance with the American Institute of Certified Public
Accountants Statement of Position 98-5, Reporting on the Costs of Start-up
Activities, the Company expenses all costs incurred in connection with the
start-up and organization of the Company.  Segmented Reporting  SFAS Number 131, Disclosure About Segments of an Enterprise
and Related Information, changed the way public companies report
information about segments of their business in their quarterly reports issued
to shareholders.  It also requires entity-wide disclosures about the
products and services an entity provides, the material countries in which it
holds assets and reports revenues and its major customers.  The company
presently operates only in the United States.  Intangible assets  Intangible
assets are stated at cost. The Company has adopted the policy of depreciation
being computed by use of the straight-line method over the term of the licence,
which is10 years. The depreciation expense was $395 for the period ended June
30, 2009.


8


Cytta Corp. (A Development Stage Company) Notes to Interim Financial Statements June 30, 2009 (Unaudited)    NOTE
2 - SUMMARY
OF SIGNIFICANT ACCOUNTING POLICIES (continued)  Earnings (Loss) Per Share of Common Stock  The Company has adopted Financial Accounting Standards Board
(FASB) Statement Number 128, Earnings per Share, (EPS) which
requires presentation of basic and diluted EPS on the face of the income
statement for all entities with complex capital structures and requires a
reconciliation of the numerator and denominator of the basic EPS computation to
the numerator and denominator of the diluted EPS computation.  In the
accompanying financial statements, basic earnings (loss) per share is computed
by dividing net income (loss) by the weighted average number of shares of common
stock outstanding during the period.  Comprehensive Income (Loss)  SFAS No. 130, Reporting Comprehensive Income, establishes
standards for reporting and display of comprehensive income and its components
in a full set of general-purpose financial statements.  From inception (May
30, 2006) to June 30, 2009, the Company had no items of other comprehensive
income.  Therefore, net loss equals comprehensive loss from inception (May
30, 2006) to June 30, 2009.  Stock-Based Compensation  The Company adopted the provisions of Statement of Financial
Accounting Standards (SFAS) No. 123(R), Share-Based Payment, which
establishes accounting for equity instruments exchanged for employee services.
 Under the provisions of SFAS 123(R), stock-based compensation cost is
measured at the grant date, based on the calculated fair value of the award, and
is recognized as an expense over the employees requisite service period
(generally the vesting period of the equity grant).  The Company accounts
for share-based payments to non-employees, in accordance with SFAS 123 (as
originally issued) and Emerging Issues Task force Issue No 96-18, Accounting
for Equity Instruments That Are Issued to Other Than Employees for Acquiring, or
in Conjunction with Selling, Goods or Services.  Revenue Recognition





Cytta Corp. (A Development Stage Company) Notes to Interim Financial Statements June 30, 2009 (Unaudited)   The Company recognizes revenue from the sale of products and
services in accordance with the Securities and Exchange Commission Staff
Accounting Bulletin No. 104 (SAB 104), Revenue Recognition in Financial
Statements.  Revenue will consist of plant sales income and will be
recognized only when all of the following criteria have been met:  (i) Persuasive evidence for an agreement exists; (ii) Delivery has occurred; (iii) The fee is fixed or determinable; and (iv) Revenue is reasonably assured.


10


Cytta Corp. (A Development Stage Company) Notes to Interim Financial Statements June 30, 2009 (Unaudited)  NOTE
2 - SUMMARY
OF SIGNIFICANT ACCOUNTING POLICIES (continued)  Recent Accounting Pronouncements  None of the following new pronouncements has current application
to the Company, but will be implemented in the Companys future financial
reporting when applicable.  In
June 2009, the FASB issued SFAS No. 168, The FASB Accounting Standards
CodificationTM and the Hierarchy of Generally Accepted Accounting
Principlesa replacement of FASB Statement No. 162.  FASB Statement
No. 162, The Hierarchy of Generally Accepted Accounting Principles,
which became effective on November 13, 2008, identified the sources of
accounting principles and the framework for selecting the principles used in
preparing the financial statements of nongovernmental entities that are
presented in conformity with GAAP. Statement 162 arranged these sources of GAAP
in a hierarchy for users to apply accordingly. Once the Codification is in
effect, all of its content will carry the same level of authority, effectively
superseding Statement 162. In other words, the GAAP hierarchy will be modified
to include only two levels of GAAP: authoritative and nonauthoritative. As a
result, this Statement replaces Statement 162 to indicate this change to the
GAAP hierarchy.  This Statement is effective for financial statements
issued for interim and annual periods ending after September 15, 2009. In
June 2009, the FASB issued SFAS No. 167, Amendments to FASB Interpretation
No. 46(R).This Statement is to improve financial reporting by
enterprises involved with variable interest entities. The Board undertook this
project to address (1) the effects on certain provisions of FASB Interpretation
No. 46 (revised December 2003), Consolidation of Variable Interest
Entities, as a result of the elimination of the qualifying special-purpose
entity concept in FASB Statement No. 166, Accounting for Transfers of
Financial Assets, and (2) constituent concerns about the application of
certain key provisions of Interpretation 46(R), including those in which the
accounting and disclosures under the Interpretation do not always provide timely
and useful information about an enterprises involvement in a variable interest
entity. This Statement shall be effective as of the beginning of each reporting
entitys first annual reporting period that begins after November 15, 2009, for
interim periods within that first annual reporting period, and for interim and
annual reporting periods thereafter.  Earlier application is
prohibited. In
June 2009, the FASB issued SFAS No. 166, Accounting for Transfers of
Financial Assetsan amendment of FASB Statement No. 140. This Statement is
to improve the relevance, representational faithfulness, and comparability of
the information that a reporting entity provides in its financial


11


Cytta Corp. (A Development Stage Company) Notes to Interim Financial Statements June 30, 2009 (Unaudited)  statements
about a transfer of financial assets; the effects of a transfer on its financial
position, financial performance, and cash flows; and a transferors continuing
involvement, if any, in transferred financial assets.   The Board
undertook this project to address (1) practices that have developed since the
issuance of FASB Statement No. 140, Accounting for Transfers and Servicing
of Financial Assets and Extinguishments of Liabilities, that are not
consistent with the original intent and key requirements of that Statement and
(2) concerns of financial statement users that many of the financial assets (and
related obligations) that have been derecognized should continue to be reported
in the financial statements of transferors.  This Statement must be applied
as of the beginning of each reporting entitys first annual reporting period
that begins after November 15, 2009, for interim periods within that first
annual reporting period and for interim and annual reporting periods thereafter.
Earlier application is prohibited.   This Statement must be applied to
transfers occurring on or after the effective date.


12


Cytta Corp. (A Development Stage Company) Notes to Interim Financial Statements June 30, 2009 (Unaudited)  NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)  Recent Accounting Pronouncements (continued)  In
May 2009, the FASB issued SFAS No. 165, Subsequent Events.  The
objective of this Statement is to establish general standards of accounting for
and disclosure of events that occur after the balance sheet date but before
financial statements are issued or are available to be issued. In particular,
this Statement sets forth: (1) The period after the balance sheet date during
which management of a reporting entity should evaluate events or transactions
that may occur for potential recognition or disclosure in the financial
statements. (2) The circumstances under which an entity should recognize events
or transactions occurring after the balance sheet date in its financial
statements. (3) The disclosures that an entity should make about events or
transactions that occurred after the balance sheet date. In accordance with this
Statement, an entity should apply the requirements to interim or annual
financial periods ending after June 15, 2009.  In May 2008, FASB issued Financial Accounting Standards No. 163,
Accounting for Financial Guarantee Insurance Contracts - an interpretation
of FASB Statement No. 60. Diversity exists in practice in accounting for
financial guarantee insurance contracts by insurance enterprises under FASB
Statement No. 60, Accounting and Reporting by Insurance Enterprises. That
diversity results in inconsistencies in the recognition and measurement of claim
liabilities because of differing views about when a loss has been incurred under
FASB Statement No. 5, Accounting for Contingencies. This Statement requires that
an insurance enterprise recognize a claim liability prior to an event of default
(insured event) when there is evidence that credit deterioration has occurred in
an insured financial obligation. This Statement also clarifies how Statement 60
applies to financial guarantee insurance contracts, including the recognition
and measurement to be used to account for premium revenue and claim liabilities.
Those clarifications will increase comparability in financial reporting of
financial guarantee insurance contracts by insurance enterprises. This Statement
requires expanded disclosures about financial guarantee insurance contracts. The
accounting and disclosure requirements of the Statement will improve the quality
of information provided to users of financial statements. This Statement is
effective for financial statements issued for fiscal years beginning after
December 15, 2008, and all interim periods within those fiscal years.  In
March 2008, FASB issued Financial Accounting Standards No. 161, Disclosure
about Derivative Instruments and Hedging Activities  an amendment to FASB
Statement No. 133. The use and complexity of derivative instruments and
hedging activities have increased significantly over the past


13


Cytta Corp. (A Development Stage Company) Notes to Interim Financial Statements June 30, 2009 (Unaudited)  several
years. Constituents have expressed concerns that the existing disclosure
requirements in FASB Statement No. 133, Accounting for Derivative
Instruments and Hedging Activities, do not provide adequate information
about how derivative and hedging activities affect an entitys financial
position, financial performance, and cash flows. Accordingly, this Statement
requires enhanced disclosures about an entitys derivative and hedging
activities and thereby improves the transparency of financial reporting. This
Statement is effective for financial statements issued for fiscal years and
interim periods beginning after November 15, 2008.


14


Cytta Corp. (A Development Stage Company) Notes to Interim Financial Statements June 30, 2009 (Unaudited)  NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)  Recent Accounting Pronouncements (continued)  In December 2007, FASB issued Financial Accounting Standards No.
160, Noncontrolling Interests in Consolidated Financial Statements - an
amendment of ARB No. 51. This statement amends ARB No. 51 to improve the
relevance, comparability, and transparency of the financial information that a
reporting entity provides in its consolidated financial statements by
establishing accounting and reporting standards of the portion of equity in a
subsidiary not attributable, directly or indirectly, to a parent.  SFAS 160
is effective for fiscal years, and interim periods with those fiscal years,
beginning on or after December 15, 2008 (that is, January 1, 2009, for entities
with calendar year-ends).  In December 2007, FASB issued a revision to Financial Accounting
Standards No. 141 (revised 2007), Business Combinations.  The objective
of this Statement is to improve the relevance, representational faithfulness,
and comparability of the information that a reporting entity provides in its
financial reports about a business combination and its effects. This Statement
applies prospectively to business combinations for which the acquisition date is
on or after the beginning of the first annual reporting period beginning on or
after December 15, 2008.  NOTE 3 -   CAPITAL STOCK  Authorized
Stock  At inception, the Company has authorized 100,000,000 common shares
and 100,000,000 preferred shares, both with a par value of $0.001 per share.
 Each common share entitles the holder to one vote, in person or proxy, on
any matter on which action of the stockholders of the corporation is sought.  Effective July 1, 2009, the Company increased the number of
authorized common shares to 2,000,000,000 shares, of which 1,900,000,000 shares
are designated as common stock par value $0.00001 per share, and 100,000,000
shares are designated as preferred stock, par value $0.001 per share.


15


Cytta Corp. (A Development Stage Company) Notes to Interim Financial Statements June 30, 2009 (Unaudited)  Share Issuance  On June 19, 2009, the Company effected a 20 for 1 forward split of
its common stock, under which each stockholder of record on July 10, 2009,
received 20 new shares of the Corporations $0.00001 par value stock for every
one share outstanding.  Since its inception, the Company has issued oustanding shares of
its common stock as follows, retroactively adjusted to give effect to the 20 for
1 forward split: Price Per  Date Description Shares  Share  Amount             06/30/06 Stock issued for cash 80,000,000 $ 0.0000625 $    5,000   09/29/06 Stock issued for cash 160,000,000 0.000125 20,000 07/11/07 Stock issued for cash 244,000,000 0.00025 61,000 01/15/09 Stock issued for services 1,400,000 0.15 210,000  06/18/08 Stock issued for license 120,000,000 0.001 120,000    06/30/09 Cumulative Totals 605,400,000   $416,000


16


Cytta Corp. (A Development Stage Company) Notes to Interim Financial Statements June 30, 2009 (Unaudited)  NOTE 3 -   CAPITAL STOCK (continued)  In addition to the above shares, 56,000,000 (2,800,000 pre-split)
shares are pending cancellation.  These shares were issued and subsequently
cancelled when the merger with Ophthalmic International, Inc. was cancelled.
However, the physical certificate was lost and thus it is being disclosed
separately, the shares were sold at par of $560 and have an offsetting reduction
on additional paid in capital of $560.  There are no preferred shares outstanding.  The Company has
no stock option plan, warrants or other dilutive securities.   NOTE 4 - PROVISION FOR INCOME TAXES  The Company recognizes the tax effects of transactions in the year
in which such transactions enter into the determination of net income,
regardless of when reported for tax purposes. Deferred taxes are provided in the
financial statements under SFAS No. 109 to give effect to the resulting
temporary differences which may arise from differences in the bases of fixed
assets, depreciation methods, allowances, and start-up costs based on the income
taxes expected to be payable in future years. Minimal development stage deferred
tax assets arising as a result of net operating loss carryforwards have been
offset completely by a valuation allowance due to the uncertainty of their
utilization in future periods. Operating loss carryforwards generated during the
period from May 30, 2006 (date of inception) through June 30, 2009 of
approximately $312,169 will begin to expire in 2026. Accordingly, deferred tax
assets of approximately $109,000 were offset by the valuation allowance that
increased by approximately $88,000 and $12,100 during the nine-month period
ended June 30, 2009 and year ended September 30, 2008, respectively. NOTE 5 - DUE TO RELATED PARTY  As of June 30, 2009 and September 31, 2008, the Company was
obligated to a stockholder, for a non-interest bearing demand loan with a
balance of $6,770 and $nil, respectively.  The Company plans to


17


Cytta Corp. (A Development Stage Company) Notes to Interim Financial Statements June 30, 2009 (Unaudited)  pay the loan back as cash flows become available.  Interest
has not been imputed on these advances due to its immaterial impact on the
financial statements.  NOTE 6 - INTANGIBLE ASSETS, NET  June 30, 2009Licensing
agreement


$
             120,000Accumulated
depreciation and amortization
(395)Net
intangible assets

$
             119,605   NOTE 7 - GOING CONCERN AND LIQUIDITY CONSIDERATIONS  The accompanying financial statements have been prepared assuming
that the Company will continue as a going concern, which contemplates the
realization of assets and the liquidation of liabilities in the normal course of
business.  As at June 30, 2009, the Company has a loss from operations of
$251,540, an accumulated deficit of $312,169, and working capital deficiency of
$15,774 and has earned no revenues since inception.  The Company intends to
fund operations through equity financing arrangements, which may be insufficient
to fund its capital expenditures, working capital and other cash requirements
for the year ending September 30, 2009.  The ability of the Company to emerge from the development stage is
dependent upon, among other things, obtaining additional financing to continue
operations, and development of its business plan.  In response to these problems, management intends to raise
additional funds through public or private placement offerings.  These factors, among others, raise substantial doubt about the
Companys ability to continue as a going concern.  The accompanying
financial statements do not include any adjustments that might result from the
outcome of this uncertainty.


18


ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS Forward-Looking Statements Except for historical information, this report contains
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  Such
forward-looking statements involve risks and uncertainties, including, among
other things, statements regarding our business strategy, future revenues and
anticipated costs and expenses.  Such forward-looking statements include,
among others, those statements including the words expects, anticipates,
intends, believes and similar language.  Our actual results may differ
significantly from those projected in the forward-looking statements. You should
carefully review the risks described in our Annual Report and in other documents
we file from time to time with the Securities and Exchange Commission.  You
are cautioned not to place undue reliance on the forward-looking statements,
which speak only as of the date of this report. We undertake no obligation to
publicly release any revisions to the forward-looking statements or reflect
events or circumstances after the date of this document. Although we believe that the expectations reflected in these
forward-looking statements are based on reasonable assumptions, there are a
number of risks and uncertainties that could cause actual results to differ
materially from such forward-looking statements. All references in this Form 10-Q to the Company, Cytta, we,
us, or our are to Cytta Corp. General Overview We were incorporated in the State of Nevada on May 30, 2006. On
December 5, 2008, we entered into an Agreement of Share Exchange and Plan of
Reorganization (the Share Exchange Agreement) and consummated a share exchange
(the Share Exchange) with Ophthalmic International, Inc. (OI), a Nevada
corporation.  The closing of the transaction took place on December 9, 2008
(the Closing Date) and resulted in the acquisition of OI (the Acquisition).
 Pursuant to the terms of the Share Exchange Agreement, we acquired all of
the outstanding capital stock of OI from the five OI shareholders for an
aggregate of 56,000,000 shares, or 69.8% of the Companys common stock.  OI
was founded in 1997 and until January 2007, was a subsidiary of Coronado
Industries, Inc., a publicly traded company.  In January 2007, OI was
acquired by G. Richard Smith, OIs President and majority shareholder and
formerly Chairman, Director and principal shareholder or Coronado Industries,
Inc.  Since January 2007, OI has operated as a private company.  As a
result of the Share Exchange Agreement, the OI shareholders transferred all
their interest in OI to the Company and, as a result, OI became our wholly owned
subsidiary. On May 13, 2009 we reached an agreement with OI to reverse this
transaction, refer to Item 5 in this report for more detail. Cytta has agreed to
return their shares in OI, in exchange for cancelling the 56,000,000 shares that
were transferred to the shareholders of OI. Following the discontinuation of our
merger with OI, we have determined to look at other ventures of merit to enhance
stockholder value.  On June 18th, 2009, the Company entered into a
Licensing


19


Agreement with Lifespan, Inc.  Lifespan had acquired the
exclusive license, for a period of ten years unless earlier terminated under the
Agreement, to manufacture, distribute and market various technologies based
internet access and computing products and services.  Under the terms of
the Agreement, Lifespan granted the Company the exclusive license to
manufacture, sell, distribute, operate, sub-license and market these products
and services in the United States.   In exchange for the license,
Lifespan has received 120,000,000 (6,000,000 pre-split) shares of the Companys
common stock, plus a license fee equal to one half of one percent (.5%) of the
net revenue derived from the sale and use of the products and services. Results of Operations We conducted no material operations during the quarter ended June
30, 2009, and do not have any present operations. During the quarter ended June
30, 2009, we generated no revenues.  Liquidity and Capital Resources The report of our auditors on our audited financial statements for
the fiscal year ended September 30, 2008, contains a going concern qualification
as we have suffered losses since our inception.  We have minimal assets and
have achieved minimal operating revenues since our inception.  We have
depended on loans and sales of equity securities to conduct operations.  As
of June 30, 2009, and September 30, 2008, we had cash of $136 and $34,536,
current assets of $136 and $34,536 and current liabilities of $15,910 and
$9,165, respectively.  Unless and until we commence material operations and
achieve material revenues, we will remain dependent on financings to continue
our operations. Plan of Operation After our merger with OI in December 2008, our intentions were to
manufacture and market a patented Vacuum Fixation Device and patented suction
rings to major medical supply companies and health care providers throughout the
world.  We conducted minimal operations in this line of business and on May
8, 2009, we decided to discontinue operations in this area and to rescind our
merger with OI.  On June 18th, 2009, the Company entered into a Licensing
Agreement with Lifespan, Inc.  Lifespan had acquired the exclusive license,
for a period of ten years unless earlier terminated under the Agreement, to
manufacture, distribute and market various technologies based internet access
and computing products and services.  Under the terms of the Agreement,
Lifespan granted the Company the exclusive license to manufacture, sell,
distribute, operate, sub-license and market these products and services in the
United States.   In exchange for the license, Lifespan has received
120,000,000 (6,000,000 pre-split) shares of the Companys common stock, plus a
license fee equal to one half of one percent (.5%) of the net revenue derived
from the sale and use of the products and services. We have minimal operating costs and expenses at the present time
due to our limited business activities. However we anticipate significantly
increasing our activities as a result of the license acquisition.
 Accordingly, we will be required to raise significant capital over the
next twelve months, in connection with our license transactions.  We do not
currently engage in any product research and development however the Companys
license may cause us to engage in research


20


and development in the foreseeable future.  We have no
present plans to purchase or sell any plant or significant equipment although we
may have to acquire some equipment related to the license transaction.  We
also have no immediate plans to add employees although we may do so in the
future as a result of the License acquisition. Off-Balance Sheet Arrangements We have never entered into any off-balance sheet financing
arrangements and have not formed any special purpose entities.  We have not
guaranteed any debt or commitments of other entities or entered into any options
on non-financial assets. ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK Not applicable. ITEM 4T. CONTROLS AND PROCEDURES Evaluation of Our Disclosure Controls and Internal
Controls Our
management is responsible for establishing and maintaining adequate internal
control over financial reporting. Our internal control over financial reporting
is a process designed to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of consolidated financial statements
for external purposes of accounting principles generally accepted in the United
States.  Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements. Therefore, even
those systems determined to be effective can provide only reasonable assurance
of achieving their control objectives. Because of the inherent limitations of
internal control, there is a risk that material misstatements may not be
prevented or detected on a timely basis by internal control over financial
reporting.  However, these inherent limitations are known features of the
financial reporting process.  Therefore, it is possible to design into the
process safeguards to reduce, though not eliminate this risk.  As of
June 30, 2009, management assessed the effectiveness of our internal control
over financial reporting.  Based on that evaluation, they concluded that,
during the period covered by this report, such internal controls and procedures
were not effective to detect the inappropriate application of US GAAP rules as
more fully described below.  The determination of ineffective internal
control is based upon the lack of separation of duties.  Management has
worked with its auditors, Moore and Associates, Charted, to correct these
deficiencies in this Form 10-Q, in order to ensure that material information
about out business and operations is recorded, processed, summarized and
publicly reported with the time periods required under the Exchange Act, and
that this information is accumulated and communicated to our management to allow
timely decisions about required disclosures.  In evaluating the
effectiveness of our internal control over financial reporting, our management
used the criteria set forth by the Committee of Sponsoring Organizations of the
Treadway Commission (COSO) in Internal Control  Integrated Framework.


21


Under
the supervision and with the participation of our senior management, including
our chief executive officer and chief financial officer, Robert Gosine, we
conducted an evaluation of the effectiveness of the design and operation of our
disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e)
under the Securities Exchange Act of 1934, as amended (the Exchange Act), as
of the end of the period covered by this quarterly report (the Evaluation
Date). Based on this evaluation, our chief executive officer and chief
financial officer concluded as of the Evaluation Date that our disclosure
controls and procedures were not effective such that the information relating to
us, including our consolidated subsidiaries, required to be disclosed in our
Securities and Exchange Commission (SEC) reports (i) is recorded, processed,
summarized and reported within the time periods specified in SEC rules and
forms, and (ii) is accumulated and communicated to our management, including our
chief executive officer and chief financial officer, as appropriate to allow
timely decisions regarding required disclosure.  Officers Certifications Appearing as exhibits to this quarterly report are
Certifications of our Chief Executive Officer and Chief Financial Officer. The
Certifications are required pursuant to Section 302 of the Sarbanes-Oxley Act of
2002 (the Section 302 Certifications). This section of the Quarterly Report
contains information concerning the Controls Evaluation referred to in the
Section 302 Certification. This information should be read in conjunction with
the Section 302 Certifications for a more complete understanding of the topics
presented. Changes in Internal Control Over Financial Reporting There have been no changes in our internal control over financial
reporting that occurred during the quarter ended June 30, 2009 that have
materially affected or are reasonably likely to materially affect our internal
control over financial reporting. PART II  OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS In the ordinary course of our business, we may from time to time
become subject to routine litigation or administrative proceedings which are
incidental to our business. We are not a party to nor are we aware of any
existing, pending or threatened lawsuits or other legal actions involving
us. ITEM 1A. RISK FACTORS Not applicable. ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS The Company issued 6,000,000 pre-split shares for a licensing
agreement.  The shares were issued based on an exemption pursuant to
Section 4(2) of the Securities Act of 1933, and Rule 506 of Regulation D
promulgated thereunder.


22


ITEM 3. DEFAULTS UPON SENIOR SECURITIES None. ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS As more fully discussed in our Form 8-K filed with the Securities
and Exchange Commission on July 1, 2009, on June 19, 2009, our stockholders and
Board of Directors approved resolutions to amend our Articles of Incorporation
(the Amendment) which Amendment was filed with the Secretary of State of the
State of Nevada on July 1, 2009, to effect an increase in the number of our
authorized capital shares to 2,000,000,000 shares, of which 1,900,000,000 shares
are designated as common stock, par value $0.00001 per share, and 100,000,000
shares are designated as preferred stock, par value $0.001 per share. ITEM 5. OTHER INFORMATION On June
19, 2009, our Board of Directors approved a twenty-for-one (20:1) forward split
of our Common Stock. The forward split was legally effective as of the close of
business on July 10, 2009 and following NASDAQ approval, the market effective
date for the forward stock split was August 11, 2009. As a result of the forward
stock split, every one share of our old Common Stock was converted into twenty
shares of our new Common Stock.  NASDAQ issued a new symbol under which our Common Stock will
trade. That symbol is CYCA.  A new CUSIP number has been issued for our
new Common Stock (12673W308) to distinguish stock certificates issued after
the effective date of the forward stock split.  On May
8, 2009, Cytta Corp. (the Registrant) entered into an agreement (the
Agreement), dated May 8, 2009, with Ophthalmic International, Inc., its
wholly-owned subsidiary (OI), pursuant to which Registrant will be reversing
the transaction of December 9, 2008, in which Registrant acquired OI in exchange
for 56,000,000 shares of Registrants restricted common stock being issued to
the shareholders of OI.  At the closing of the Agreement, the shareholders
of the 56,000,000 shares of Registrants common stock will return those shares
to Registrant in exchange for Registrant delivering to them their pro-rata
shares of outstanding OI common stock. The transaction closed on May 13,
2009.  At the
close of the Agreement, on May 13, 2009, G. Richard Smith, the sole Director,
Principal Executive Officer and Principal Financial Officer of Registrant,
resigned from all of his positions after appointing Mr. Robert Gosine as the
sole Director and Principal Executive Officer.  Mr. Gosine had been a
Director and Principal Executive Officer of the Registrant prior to December 9,
2008.  ITEM 6. EXHIBITS Exhibit No. Description 31.1 / 31.2 Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Executive
and Financial Officer


23


32.1 / 32.2 Rule 1350 Certification of Principal Executive and Financial
Officer  SIGNATURES  Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.    CYTTA CORP.   Dated:  August 19, 2009 By: /s/ Stephen Spalding Stephen
Spalding President, Principal Executive and Financial Officer


24